Selected research
Market Structure
Global Liver Cirrhosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Liver Cirrhosis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Liver Cirrhosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Liver Cirrhosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Liver Cirrhosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Liver Cirrhosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Liver Cirrhosis include Johnson & Johnson, Merck, GlaxoSmithKline, Bristol-Myers Squibb, Intercept Pharmaceuticals, Instituto Grifols, Gwo Xi Stem Cell Applied Technology, Gilead Sciences and F Hoffman La-Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Liver Cirrhosis market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Liver Cirrhosis and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Liver Cirrhosis revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Liver Cirrhosis market size, projected growth trends, production technologies, key applications, and end-use industries.
Liver Cirrhosis Segment by Company
Johnson & Johnson
Merck
GlaxoSmithKline
Bristol-Myers Squibb
Intercept Pharmaceuticals
Instituto Grifols
Gwo Xi Stem Cell Applied Technology
Gilead Sciences
F Hoffman La-Roche
Conatus Pharmaceuticals
Liver Cirrhosis Segment by Type
Cryptogenic Cirrhosis
Cardiac Cirrhosis
Atrophic Cirrhosis
Alcoholic Cirrhosis
Biliary Cirrhosis
Liver Cirrhosis Segment by Application
Hospitals
Specialty Clinics
Liver Cirrhosis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liver Cirrhosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liver Cirrhosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liver Cirrhosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Liver Cirrhosis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Liver Cirrhosis industry.
Chapter 3: Detailed analysis of Liver Cirrhosis companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liver Cirrhosisrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cryptogenic Cirrhosis
- Cardiac Cirrhosis
- Atrophic Cirrhosis
- Alcoholic Cirrhosis
- Biliary Cirrhosis
Applications
- Hospitals
- Specialty Clinics
Companies covered
- Johnson & Johnson
- Merck
- GlaxoSmithKline
- Bristol-Myers Squibb
- Intercept Pharmaceuticals
- Instituto Grifols
- Gwo Xi Stem Cell Applied Technology
- Gilead Sciences
- F Hoffman La-Roche
- Conatus Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Liver Cirrhosis Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Cryptogenic Cirrhosis
- 1.2.3 Cardiac Cirrhosis
- 1.2.4 Atrophic Cirrhosis
- 1.2.5 Alcoholic Cirrhosis
- 1.2.6 Biliary Cirrhosis
- 1.3 Market Analysis by Application
- 1.3.1 Global Liver Cirrhosis Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospitals
- 1.3.3 Specialty Clinics
- 1.4 Global Market Growth Prospects
- 1.5 Global Liver Cirrhosis Growth Trends by Region
- 1.5.1 Global Liver Cirrhosis Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Liver Cirrhosis Market Size by Region (2021-2026)
- 1.5.3 Liver Cirrhosis Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Liver Cirrhosis Market Dynamics
- 2.1 Liver Cirrhosis Industry Trends
- 2.2 Liver Cirrhosis Industry Drivers
- 2.3 Liver Cirrhosis Industry Opportunities and Challenges
- 2.4 Liver Cirrhosis Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Liver Cirrhosis Revenue by Company (2021-2026)
- 3.2 Global Liver Cirrhosis Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Liver Cirrhosis Key Company Head office and Area Served
- 3.4 Global Liver Cirrhosis Company, Product Type & Application
- 3.5 Global Liver Cirrhosis Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Liver Cirrhosis Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Liver Cirrhosis Players Market Share by Revenue in 2025
- 3.6.3 2025 Liver Cirrhosis Tier 1, Tier 2, and Tier 3
4 Liver Cirrhosis Market by Type
- 4.1 Global Liver Cirrhosis Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Liver Cirrhosis Market Size by Type (2021-2032)
- 4.3 Global Liver Cirrhosis Market Size Share by Type (2021-2032)
5 Liver Cirrhosis Market by Application
- 5.1 Global Liver Cirrhosis Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Liver Cirrhosis Market Size by Application (2021-2032)
- 5.3 Global Liver Cirrhosis Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Johnson & Johnson
- 6.1.1 Johnson & Johnson Company Information
- 6.1.2 Johnson & Johnson Business Overview
- 6.1.3 Johnson & Johnson Liver Cirrhosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Johnson & Johnson Liver Cirrhosis Product Portfolio
- 6.1.5 Johnson & Johnson Recent Developments
- 6.2 Merck
- 6.2.1 Merck Company Information
- 6.2.2 Merck Business Overview
- 6.2.3 Merck Liver Cirrhosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Merck Liver Cirrhosis Product Portfolio
- 6.2.5 Merck Recent Developments
- 6.3 GlaxoSmithKline
- 6.3.1 GlaxoSmithKline Company Information
- 6.3.2 GlaxoSmithKline Business Overview
- 6.3.3 GlaxoSmithKline Liver Cirrhosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 GlaxoSmithKline Liver Cirrhosis Product Portfolio
- 6.3.5 GlaxoSmithKline Recent Developments
- 6.4 Bristol-Myers Squibb
- 6.4.1 Bristol-Myers Squibb Company Information
- 6.4.2 Bristol-Myers Squibb Business Overview
- 6.4.3 Bristol-Myers Squibb Liver Cirrhosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Bristol-Myers Squibb Liver Cirrhosis Product Portfolio
- 6.4.5 Bristol-Myers Squibb Recent Developments
- 6.5 Intercept Pharmaceuticals
- 6.5.1 Intercept Pharmaceuticals Company Information
- 6.5.2 Intercept Pharmaceuticals Business Overview
- 6.5.3 Intercept Pharmaceuticals Liver Cirrhosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Intercept Pharmaceuticals Liver Cirrhosis Product Portfolio
- 6.5.5 Intercept Pharmaceuticals Recent Developments
- 6.6 Instituto Grifols
- 6.6.1 Instituto Grifols Company Information
- 6.6.2 Instituto Grifols Business Overview
- 6.6.3 Instituto Grifols Liver Cirrhosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Instituto Grifols Liver Cirrhosis Product Portfolio
- 6.6.5 Instituto Grifols Recent Developments
- 6.7 Gwo Xi Stem Cell Applied Technology
- 6.7.1 Gwo Xi Stem Cell Applied Technology Company Information
- 6.7.2 Gwo Xi Stem Cell Applied Technology Business Overview
- 6.7.3 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Product Portfolio
- 6.7.5 Gwo Xi Stem Cell Applied Technology Recent Developments
- 6.8 Gilead Sciences
- 6.8.1 Gilead Sciences Company Information
- 6.8.2 Gilead Sciences Business Overview
- 6.8.3 Gilead Sciences Liver Cirrhosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Gilead Sciences Liver Cirrhosis Product Portfolio
- 6.8.5 Gilead Sciences Recent Developments
- 6.9 F Hoffman La-Roche
- 6.9.1 F Hoffman La-Roche Company Information
- 6.9.2 F Hoffman La-Roche Business Overview
- 6.9.3 F Hoffman La-Roche Liver Cirrhosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 F Hoffman La-Roche Liver Cirrhosis Product Portfolio
- 6.9.5 F Hoffman La-Roche Recent Developments
- 6.10 Conatus Pharmaceuticals
- 6.10.1 Conatus Pharmaceuticals Company Information
- 6.10.2 Conatus Pharmaceuticals Business Overview
- 6.10.3 Conatus Pharmaceuticals Liver Cirrhosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Conatus Pharmaceuticals Liver Cirrhosis Product Portfolio
- 6.10.5 Conatus Pharmaceuticals Recent Developments
7 North America
- 7.1 North America Liver Cirrhosis Market Size (2021-2032)
- 7.2 North America Liver Cirrhosis Market Size by Type
- 7.2.1 North America Liver Cirrhosis Market Size by Type (2021-2026)
- 7.2.2 North America Liver Cirrhosis Market Size by Type (2027-2032)
- 7.2.3 North America Liver Cirrhosis Market Share by Type (2021-2032)
- 7.3 North America Liver Cirrhosis Market Size by Application
- 7.3.1 North America Liver Cirrhosis Market Size by Application (2021-2026)
- 7.3.2 North America Liver Cirrhosis Market Size by Application (2027-2032)
- 7.3.3 North America Liver Cirrhosis Market Share by Application (2021-2032)
- 7.4 North America Liver Cirrhosis Market Size by Country
- 7.4.1 North America Liver Cirrhosis Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Liver Cirrhosis Market Size by Country (2021-2026)
- 7.4.3 North America Liver Cirrhosis Market Size by Country (2027-2032)
- 7.4.4 North America Liver Cirrhosis Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Liver Cirrhosis Market Size (2021-2032)
- 8.2 Europe Liver Cirrhosis Market Size by Type
- 8.2.1 Europe Liver Cirrhosis Market Size by Type (2021-2026)
- 8.2.2 Europe Liver Cirrhosis Market Size by Type (2027-2032)
- 8.2.3 Europe Liver Cirrhosis Market Share by Type (2021-2032)
- 8.3 Europe Liver Cirrhosis Market Size by Application
- 8.3.1 Europe Liver Cirrhosis Market Size by Application (2021-2026)
- 8.3.2 Europe Liver Cirrhosis Market Size by Application (2027-2032)
- 8.3.3 Europe Liver Cirrhosis Market Share by Application (2021-2032)
- 8.4 Europe Liver Cirrhosis Market Size by Country
- 8.4.1 Europe Liver Cirrhosis Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Liver Cirrhosis Market Size by Country (2021-2026)
- 8.4.3 Europe Liver Cirrhosis Market Size by Country (2027-2032)
- 8.4.4 Europe Liver Cirrhosis Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Liver Cirrhosis Market Size (2021-2032)
- 9.2 China Liver Cirrhosis Market Size by Type
- 9.2.1 China Liver Cirrhosis Market Size by Type (2021-2026)
- 9.2.2 China Liver Cirrhosis Market Size by Type (2027-2032)
- 9.2.3 China Liver Cirrhosis Market Share by Type (2021-2032)
- 9.3 China Liver Cirrhosis Market Size by Application
- 9.3.1 China Liver Cirrhosis Market Size by Application (2021-2026)
- 9.3.2 China Liver Cirrhosis Market Size by Application (2027-2032)
- 9.3.3 China Liver Cirrhosis Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Liver Cirrhosis Market Size (2021-2032)
- 10.2 Asia Liver Cirrhosis Market Size by Type
- 10.2.1 Asia Liver Cirrhosis Market Size by Type (2021-2026)
- 10.2.2 Asia Liver Cirrhosis Market Size by Type (2027-2032)
- 10.2.3 Asia Liver Cirrhosis Market Share by Type (2021-2032)
- 10.3 Asia Liver Cirrhosis Market Size by Application
- 10.3.1 Asia Liver Cirrhosis Market Size by Application (2021-2026)
- 10.3.2 Asia Liver Cirrhosis Market Size by Application (2027-2032)
- 10.3.3 Asia Liver Cirrhosis Market Share by Application (2021-2032)
- 10.4 Asia Liver Cirrhosis Market Size by Country
- 10.4.1 Asia Liver Cirrhosis Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Liver Cirrhosis Market Size by Country (2021-2026)
- 10.4.3 Asia Liver Cirrhosis Market Size by Country (2027-2032)
- 10.4.4 Asia Liver Cirrhosis Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Liver Cirrhosis Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Liver Cirrhosis Market Size by Type
- 11.2.1 South America, Middle East & Africa Liver Cirrhosis Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Liver Cirrhosis Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Liver Cirrhosis Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Liver Cirrhosis Market Size by Application
- 11.3.1 South America, Middle East & Africa Liver Cirrhosis Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Liver Cirrhosis Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Liver Cirrhosis Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Liver Cirrhosis Market Size by Country
- 11.4.1 South America, Middle East & Africa Liver Cirrhosis Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Liver Cirrhosis Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Liver Cirrhosis Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Liver Cirrhosis Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst